Dermot Murnaghan Joins Prostate Cancer Research As An Ambassador

Former News Presenter Dermot Murnaghan has joined Prostate Cancer Research as an ambassador. In this role he will help drive forward the charity’s campaign for a national screening programme for men at higher risk of prostate cancer.

The announcement follows Murnaghan’s recent disclosure that he is living with stage four prostate cancer, bringing personal significance to his new role and highlighting the pressing need for screening reform.

As a Prostate Cancer Research ambassador, Murnaghan will be supporting the charity’s mission of advancing groundbreaking research and treatments to create a future where prostate cancer no longer impacts lives.

This backing from the former ITV, BBC, and Sky News journalist comes at a crucial time for Prostate Cancer Research, as its Proactive For Your Prostate campaign continues to gain momentum. The campaign is calling for the immediate introduction of a targeted national screening programme for men at high risk, alongside increased investment in improved diagnostic tools to pave the way for a universal screening programme in the future.

Prostate cancer is now the most commonly diagnosed cancer among men in the UK. Early detection is crucial, as a late-stage diagnosis significantly limits treatment options and can greatly diminish quality of life.

“We are honoured to welcome Dermot Murnaghan as an ambassador for Prostate Cancer Research. His commitment to our mission of transforming the landscape of prostate cancer diagnosis, treatment and care is truly valued. With urgent need for nationwide screening, Dermot’s support will be instrumental in raising awareness and saving lives.”

ENDS

Prostate Cancer Research: Kath Coleman [email protected]; Jess Farmery
[email protected]

Prostate Cancer Research is a patient-centric research and information provision charity dedicated to improving and saving the lives of people with prostate cancer.

As well as working towards greater equity, access to and parity of care, they fund innovative research projects at world-leading institutions that are working towards breakthroughs in the prevention, diagnosis and treatment of prostate cancer. This includes research into tackling health inequities, improving current treatments and developing novel drug targets.

The charity also supports translational research to ensure any breakthroughs have a greater chance of reaching the patients who need them. Over the past two years, they have more than trebled their research, established the infopool, an educational website to support and empower patients and launched Prostate Progress, the UK’s first patient-centric data platform powered by NHS data.

For more information, please visit: www.pcr.org.uk